Issy les Moulineaux, France

Mäia Chanrion

This inventor holds 1 USPTO granted patent. Top assignees: Les Laboratoires Servier, Vernalis &r&d) Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mäia Chanrion. Retrieved from https://idiyas.com/inventor/mäia-chanrion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mäia Chanrion: Innovator in Pharmaceutical Chemistry

Introduction

Mäia Chanrion is a notable inventor based in Issy les Moulineaux, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development efforts.

Latest Patents

Mäia Chanrion holds a patent for "(Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them." This patent includes compounds of formula (I), wherein R, R, J, K, L, n, and W are defined in the description. The medicinal products derived from this patent are useful in treating conditions that require pro-apoptotic and/or anti-proliferative agents. He has 1 patent to his name.

Career Highlights

Throughout his career, Chanrion has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Les Laboratoires Servier and Vernalis (R&D) Limited. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Mäia Chanrion has collaborated with esteemed colleagues, including András Kotschy and Csaba Wéber. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

Mäia Chanrion is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in medicinal products. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…